- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Generics account for increasing total Rxs dispensed
Doug Long, VP of industry relations for IMS Health, told attendees of the recent GPhA annual meeting that the generic industry is riding high.
Doug Long, VP of industry relations for IMS Health, told attendees of the recent GPhA annual meeting that the generic industry is riding high. "In 2001, generics represented 47% of prescriptions dispensed in the U.S.; today they represent 61% and it looks like it's going to go much higher in 2007." Long said that total Rx volume increased by 4.6% industrywide in 2006, while generic prescriptions increased by 13%, three times faster than the market. On a dollar basis, the total pharmaceutical market grew by 8.3%, while the generic business grew by 22.4%.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Antiseizure Medications Linked to Serious Potential Reaction, FDA Warns
November 30th 2023Levetiracetam and clobazam can cause Drug Reaction with Eosinophilia and Systemic Symptoms, which can start as a rash but progress quickly, potentially resulting in injury to internal organs, hospitalization, and death.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
